Cite
Glycovaccine Design: Optimization of Model and Antitubercular Carrier Glycosylation via Disuccinimidyl Homobifunctional Linker.
MLA
Tengattini, Sara, et al. “Glycovaccine Design: Optimization of Model and Antitubercular Carrier Glycosylation via Disuccinimidyl Homobifunctional Linker.” Pharmaceutics, vol. 15, no. 5, Apr. 2023. EBSCOhost, https://doi.org/10.3390/pharmaceutics15051321.
APA
Tengattini, S., Rubes, D., Serra, M., Piubelli, L., Pollegioni, L., Calleri, E., Bavaro, T., Massolini, G., Terreni, M., & Temporini, C. (2023). Glycovaccine Design: Optimization of Model and Antitubercular Carrier Glycosylation via Disuccinimidyl Homobifunctional Linker. Pharmaceutics, 15(5). https://doi.org/10.3390/pharmaceutics15051321
Chicago
Tengattini, Sara, Davide Rubes, Massimo Serra, Luciano Piubelli, Loredano Pollegioni, Enrica Calleri, Teodora Bavaro, Gabriella Massolini, Marco Terreni, and Caterina Temporini. 2023. “Glycovaccine Design: Optimization of Model and Antitubercular Carrier Glycosylation via Disuccinimidyl Homobifunctional Linker.” Pharmaceutics 15 (5). doi:10.3390/pharmaceutics15051321.